The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland:

Similar documents
Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

European status report on alcohol and health Leadership, awareness and commitment

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

The cancer burden in the European Union and the European Region: the current situation and a way forward

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Alcohol-related harm in Europe and the WHO policy response

ECDC and Spanish Ministry of Health workshop:

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Key issues for HIV testing and

European Status report on Alcohol and Health

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

Access to treatment and disease burden

Q1 What age are you?

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Highlighting in the WHO European Region:

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

WCPT COUNTRY PROFILE December 2017 SERBIA

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Where we stand in EFORT

Summary. Primary care data. Week 49/2014. Season

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

ECDC s role in the fight against HIV/AIDS in Europe

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Inequality in injury risks

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

11 Melanoma of the skin

Engagement in language assessment / Regions of Europe

Overview of drug-induced deaths in Europe - What does the data tell us?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Monthly measles and rubella monitoring report

Measles and rubella monitoring January 2015

Smokefree Policies in Europe: Are we there yet?

LEBANON. WCPT COUNTRY PROFILE December 2018

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

DENMARK. WCPT COUNTRY PROFILE December 2018

Cardiovascular disease in Europe: epidemiological update 2016

HPAI H5(N8) in Member States in poultry, captive and wild birds

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

The challenge of obesity in the WHO European Region

Table 9.1 Summary information for stomach cancer in Ireland,

Welcome to the new EURO Immunization Monitor

European Collaboration on Dementia. Luxembourg, 13 December 2006

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

GERMANY. WCPT COUNTRY PROFILE December 2018

The health economic landscape of cancer in Europe

Table 7.1 Summary information for lung cancer in Ireland,

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

Better Health for All in Latvia

Behavioural indicators in men who have sex with men

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area

Main developments in past 24 hours

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Best practices in collecting and processing data in CRC screening and after it

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

Hepatitis C in the WHO European Region

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

REVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015

Development of Palliative Care services in different countries

Key Highlights continued

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

European Association of Dental Public Health Prevention of Oral Cancer

ICM: Trade-offs in the fight against HIV/AIDS

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Lymphogranuloma venereum

Fakoya et al. BMC Public Health (2015) 15:561 DOI /s

HIV/AIDS Joint Action HA-REACT

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

THE BENCHMARK. UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response.

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Scaling up priority HIV/AIDS interventions in the health sector

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Childlessness in Europe: Reconstructing long-term trends among women born in

WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States

Overall survival: 1 st line therapy

Table 6.1 Summary information for colorectal cancer in Ireland,

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Acknowledgements. Wild birds and the risk of a pandemic. Overview of the presentation

AIDS by the Numbers: Where Do We Stand with ? Peter Ghys, UNAIDS

Transcription:

European Journal of Public Health, Vol. 21, No. 5, 62 626 ß The Author 21. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved. doi:1.193/eurpub/ckq15 Advance Access published on 4 November 21... The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: 1999 26 Julia Del Amo 1,2,3, Giedrius Likatavičius 4, Santiago Pérez-Cachafeiro 1,2, Victoria Hernando 1,2, Cristina González 1,2, Inma Jarrín 1,2, Teymur Noori 4, Françoise F. Hamers 5, Francisco Bolúmar 2,6 1 National Center of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain 2 Ciber de Epidemiologia y Salud Pública (CIBERESP), Spain 3 Department of Health Sciences, University Rey Juan Carlos I, Madrid, Spain 4 Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden 5 Haute Autorité de Santé, Saint Denis, Paris, France 6 Department of Public Health Sciences, Universidad de Alcalá, Madrid, Spain Correspondence: Julia del Amo, National Center of Epidemiology, Instituto de Salud Carlos III, Avda. Monforte de Lemos, 5 2829, Madrid, Spain, tel: +34 918222142, fax: +34 913877815, e-mail: jdamo@isciii.es Received 15 March 21, accepted 27 August 21 Background: To describe the epidemiology of HIV and AIDS by geographical origin in the EU,1999 26. Methods: AIDS and HIV cases from the EU 27, Norway and Iceland reported to European Centre for Epidemiological Monitoring of AIDS were analysed. Results: Of 75 21 AIDS reports over 1999 26, 35% were migrants. Of 2988 heterosexual AIDS reports in 26, 5% were migrants, largely from Sub-Saharan Africa (SSA), 2% of 144 AIDS cases in men who have sex with men (MSM) were migrants from Latin-America and Western Europe. Of 57 mother-to-child transmission (MTCT) AIDS cases, 23% were from SSA. AIDS cases decreased from 1999 to 26 in natives (42%), Western Europeans (4%) and North Africa and Middle East (34%), but increased in people from SSA (by 89%), Eastern Europe (by 2%) and Latin-America (5%). Of 17 646 HIV infections in men and 966 in females in 26, 49 and 76% were migrants, largely from SSA. Of 169 MTCT infections, 41% were from SSA. Conclusion: Migrants, largely from SSA, represent a considerable proportion of AIDS and HIV reports in EU, especially among heterosexual and MTCT infections. Their contribution is higher among female reports. A substantial percentage of diagnoses in MSM are migrants, largely from Western Europe and Latin-America. Keywords: acquired immunodeficiency syndrome, epidemiology, Europe, HIV infections, transient, migrants... Introduction he global HIV/AIDS pandemic reflects the gross socio- and gender inequalities between industrialized Teconomic and non-industrialized countries. In 27, 33 million people were living with HIV/AIDS (PLWHA) and >96% of the new HIV infections took place in low- and middle-income countries. 1 Of all PLWHA, 22.5 million live in Sub-Saharan Africa (SSA) where adult HIV prevalence is 5%, considerably higher than the.8% HIV world estimate. The Caribbean, with 1% prevalence, ranks second followed by Eastern Europe, with a.9% HIV prevalence. The female-to-male ratio of new HIV infections is significantly higher in SSA and The Caribbean than in Western countries. 1 According to the International Organization of Migration, 2 million people, 49.6% women, were international migrants in 26. 2 The United Nations (UN) defines an international migrant as anyone who changes his/her country of usual residence. 2 The most common push factor for migration is seeking an economic improvement. This economic gradient, coupled with demographic imbalances worldwide, explains why two-thirds of migrants travel from developing to developed countries. 2 Apart from economic migration, political and social dissidence force people to migrate. Particularly relevant to HIV epidemiology is the group of people who are persecuted because of their sexual identity. In 25, Europe had 64 million international migrants representing 8.8% of the population, 3 and the largest proportions of these migrants were born in neighbouring countries. The guidelines on HIV/AIDS and human rights developed by the UN Office of the High Commissioner for Human Rights and the Joint United Programme on HIV recognized migrants as one of the most vulnerable groups to HIV infection and its consequences. 4 These guidelines call upon governments to fulfil their obligations on non-discrimination, rights to health and employment to reduce their vulnerability. 4 The HIV epidemic is a major public health problem in the EU; the number of HIV infections has not ceased to increase since HIV reporting mechanisms came into place around 1999. 5,6 Heterosexually transmitted HIV infection accounts for the largest number of people with HIV in Europe; a considerable proportion of these HIV cases are migrants, largely from SSA. 5,6 Male-to-male sex accounts for most of the ongoing HIV transmission at EU level but hardly any data on the geographical origin of these men are available. Since 1998, former EuroHIV collects information on the geographical origin of all cases irrespective of their transmission category. The rationale behind this move was that health inequalities, including those by migrant status, need to be Downloaded from https://academic.oup.com/eurpub/article-abstract/21/5/62/5141 on 3 January 218

Epidemiology of HIV infection in Europe 621 monitored for developing appropriate responses. We aim to describe the epidemiology of reported HIV infections and AIDS cases according to geographical origin, sex and transmission category in the EU 27, Norway and Iceland in 1999 26. Methods We used AIDS cases and HIV infections from National registries from the EU 27, Norway and Iceland reported to former EuroHIV, now based at the European Centre for Disease Prevention and Control (ECDC), from 1999 to 26. Data on AIDS diagnoses were adjusted for reporting delays. HIV data were reported as date of notification. Since 1998, EuroHIV collected information on the origin of HIV/AIDS cases. It was recommended to derive this information from nationality or country of birth. The variable was classified as: people whose origin is the same as the reporting country, West Europe, Central Europe, East Europe, SSA, East Asia and Pacific, Australia and New Zealand, South and Southeast Asia, North Africa and Middle East, North America, Caribbean, Latin-America, Foreigner and unknown. We examined absolute numbers and proportions of migrants according to geographical origin among AIDS and HIV reports from 1999 to 26, stratified by sex and transmission category. We calculated relative changes in the number of AIDS cases in 26 compared with 1999. We plotted the proportion of migrants among HIV infections reported in 26 by country classified in five groups according to estimated HIV incidence per million people. 6 Results Of the 75 21 AIDS cases (55 664 were men) reported from 1999 to 26, 26 98 (35%) were migrants. The proportion of migrants among the female AIDS cases, 46%, was higher than in male AIDS cases, 31%. Out of 6746 AIDS reports, 2472 (37%) were migrants (table 1) in 26. The proportion of women among AIDS cases in migrants (4%) was higher than in cases whose geographical origin was the reporting country (28%). The 62 AIDS reports in SSA men and the 623 in SSA women accounted for 12 and 33% of the total number of AIDS cases reported for each sex in 26. The number of AIDS cases in the European region experienced a 42% decline from 1999 to 26 in natives and migrants from Western Europe, but increases are observed in migrants from Eastern Europe (by 2%), SSA (by 89%) and Latin-America (by 5%). The largest number, in absolute and relative terms, of migrants among AIDS reports from 1999 to 26 is observed in heterosexually transmitted cases (figure 1). Of all the heterosexual AIDS reports with known geographical origin in 26, 1373 (5%) were from a country different to that reporting the case, largely from SSA (figure 1). Of 57 AIDS cases reported in 26 due to mother-to-child transmission (MTCT) with known geographical origin, 23% were from SSA. Also, close to 2% of AIDS cases in men having sex with men (MSM) were migrants and the commonest origins were Latin-America and other Western European countries. Among 1545 cases in IDU diagnosed during 26, 7% were migrants, largely from Western Europe and North Africa and Middle East (figure 1). Marked increases from 1999 to 26 in the number of heterosexuals from SSA among AIDS cases are seen (figure 1). The proportion of migrants from Latin-America (3.% in 1999 vs. 7.5% in 26) and Western Europe (2.9% in 1999 vs. 3.6% in 26) among AIDS reports in MSM has also increased (figure 1). From 1999 to 26, of the 16 222 tuberculosis (TB) cases reported as initial AIDS-defining condition (ADC), 828 were migrants (3883 from SSA) and 2684 had unknown Table 1 Distribution by geographical origin and sex of AIDS cases and number of newly diagnosed HIV infections reported in 26 Total Male Female AIDS cases Total 6746 4885 1861 Cases in migrants 2472 1478 994 Geographical origin of cases Country of report 4276 344 872 West Europe a 113 14 9 Centre Europe b 55 36 19 East Europe c 24 19 5 Sub Saharan Africa 1225 62 623 East Asia and Pacific 1 1 Australia and New Zealand 1 1 South and southeast Asia 12 61 59 North Africa and Middle East 92 72 2 North America 14 14 Caribbean 78 51 27 Latin-America 29 149 6 Others 11 7 4 Unknown 518 355 163 HIV infections d Total 26 712 17 646 966 Cases in migrants 15 517 8667 685 Geographical origin of cases Country of report 11 195 8979 2216 West Europe 539 461 78 Centre Europe 251 182 69 East Europe 222 137 85 Sub Saharan Africa 546 191 3145 East Asia and Pacific 34 31 3 Australia and New Zealand 14 14 South and southeast Asia 363 184 179 North Africa and Middle East 214 161 53 North America 59 57 2 Caribbean 329 168 161 Latin-America 456 345 111 Others 178 124 54 Unknown 7812 492 291 a: West Europe countries: Andorra, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, UK. b: Centre Europe countries: Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Hungary, Former Yugoslav Republic of Macedonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, Turkey. c: East Europe countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Republic of Moldova, Russian Federation, Tajikistan, Turkmenistan, Ukraine, Uzbekistan. d: All EU countries except Bulgaria, Italy, Malta and Rumania due to missing HIV data. geographical origin. Prevalence of TB as initial ADC was 4% in Sub-Saharan Africans, 4% in Eastern Europeans, 32% in Southeast Asians, 3% in Latin-Americans, 16% in natives and 8% in North-Americans (figure 2). Among heterosexuals, TB represented 3499 (41%) of initial ADC in Sub-Saharan Africans, 26 (46%) in Eastern Europeans, 173 (32%) in Southeast Asians, 255 (15%) in natives and between 2% and 25% in people from Central Europe, North Africa and Middle East, Caribbean and Latin-America. Prevalence of TB was higher in Injecting drug user (IDU), followed by heterosexuals, compared with MSM but the differences by geographical origin are maintained (data not shown). In 26, of 26 712 HIV infections reported, 15 517 (58%) were migrants and 7812 (29%) did not record the geographical Downloaded from https://academic.oup.com/eurpub/article-abstract/21/5/62/5141 on 3 January 218

622 European Journal of Public Health 25 Men who have sex with men 4 35 IDU 2 3 15 25 2 1 15 5 1 5 1999 (n=2496) 2 (n=2365) 21 (n=1937) 22 (n=192) 23 (n=1911) 24 (n=1823) 25 (n=1776) 26 (n=141) 1999 (n=441) 2 (n=3463) 21 (n=314) 22 (n=2778) 23 (n=2587) 24 (n=229) 25 (n=24) 26 (n=1557) Natives East Europe Australia & New Zealand North America Others West Europe Sub Saharan Africa South & south-east Asia Caribbean Unknown Centre Europe East Asia & Pacific North Africa & Middle East Latin America 4 Heterosexual 12 MTCT 35 3 25 1 8 2 6 15 1 5 4 2 1999 (n=3355) 2 (n=3544) 21 (n=3551) 22 (n=389) 23 (n=3777) 24 (n=3741) 25 (n=3589) 26 (n=2989) 1999 (n=19) 2 (n=19) 21 (n=93) 22 (n=85) 23 (n=88) 24 (n=73) 25 (n=6) 26 (n=61) Figure 1 Trends in AIDS cases by geographical origin within each transmission category: 1999 26 5% 4% 39,7% 4,% 36,6% 3% 2% 16,4% 21,2% 19,9% 19,7% 31,7% 23,3% 23,5% 3,1% 26,7% 1% 8,% % Natives (8,28/48,962) West Europe (279/1,318) Centre Europe (114/573) East Europe (58/146) Sub Saharan Africa (3,883/9,711) East Asia & Pacific (12/61) South & Southeast Asi (267/843) North Africa & Middle East (218/937) North America (9/113) Caribbean (166/75) Latin America (44/1,463) Others (67/183) Unknown (2,684/1,56) Country of origin Figure 2 Cumulative percentage of TB as the initial AIDS-defining condition in AIDS cases reported, 1999 26 Downloaded from https://academic.oup.com/eurpub/article-abstract/21/5/62/5141 on 3 January 218

Epidemiology of HIV infection in Europe 623 7 Men who have sex with men 35 IDU 6 3 5 25 4 2 3 15 2 1 1 5 1999 (n=2858) 2 (n=363) 21 (n=2768) 22 (n=3648) 23 (n=493) 24 (n=65) 25 (n=698) 26 (n=6616) 1999 (n=152) 2 (n=3537) 21 (n=262) 22 (n=2511) 23 (n=2149) 24 (n=2218) 25 (n=194) 26 (n=1612) Natives West Europe Centre Europe East Europe Sub Saharan Africa East Asia & Pacific Australia & New Zealand South & south-east Asia North Africa & Middle East North America Caribbean Latin America Others Unknown 15 Heterosexual 3 MTCT 9 75 225 6 15 45 3 75 15 1999 (n=359) 2 (n=452) 21 (n=4868) 22 (n=6366) 23 (n=956) 24 (n=1144) 25 (n=11429) 26 (n=9944) 1999 (n=124) 2 (n=176) 21 (n=163) 22 (n=22) 23 (n=258) 24 (n=298) 25 (n=237) 26 (n=191) Figure 3 Trends in HIV cases by geographical origin within each transmission category: 1999 26 origin (table 1). The proportion of women (44%) among HIV reports in migrants was higher than in natives (34%). People from SSA are the second largest group among HIV reports in the EU (table 1), migrants from other Western European country are the third, followed by Latin-Americans, Southeast Asians and Caribbeans (table 1). The numbers of men and women from SSA among HIV infections reported in 26 were 191 and 3145, respectively (table 1). The number of HIV reports in women from SSA exceeds by close to 1 that of native women and by over 1 that of men from SSA. It has to be acknowledged that there are 291 HIV infections in females with unknown geographical origin. After SSA, those from Western Europe account for the largest group followed by Latin-Americans. After Sub-Saharan African women, the most common origins of HIV infections in female migrants were Southeast Asia and Caribbean (table 1). As it can be seen in figure 3, the number of HIV reports acquired heterosexually in migrants ceased to increase by 26, and even a slight decline was observed, coupled with a slight increase in the number of cases with unknown geographical origin. The largest number of migrants, both in absolute and relative terms, was observed among heterosexually transmitted infections whose commonest origin was SSA (figure 3). Of the Downloaded from https://academic.oup.com/eurpub/article-abstract/21/5/62/5141 on 3 January 218 169 MTCT HIV reports with known geographical origin, 41% were from SSA (figure 3). Of the 548 HIV infections with known geographical origin in MSM, 18% were migrants and the commonest regions of origin were Western Europe, Latin-America and North-Africa and Middle East. Among the 159 HIV infections in IDU with known geographical origin, 14% migrants, largely from Western and Eastern Europe (figure 3). Interpreting absolute trends between 1999 and 26 is difficult due to the major changes in the implementation of the HIV reporting systems and it seems that the relative contribution of migrants to the HIV infections reported has increased over time for all transmission categories, especially in heterosexuals (figure 3). There is substantial heterogeneity in the proportion of migrants among HIV reports between countries (figure 4). Among countries with HIV incidence below 2 cases per million, largely Central Europe, the proportion of migrants among HIV reports is low, while is higher for most of the countries with high HIV incidence, with notable exceptions like Estonia. Finally, for most countries, the most common region of origin of the AIDS and HIV reports was SSA, with some exceptions like Spain where the absolute number of people from Latin-America outnumbered that of SSA.

624 European Journal of Public Health Poland Slovakia >2 1-199 5-99 21-49 <2 Slovenia Hungary Czech Republic Lithuania Spain** Denmark Finland Iceland Sweden Chipre Greece Germany France Netherlands Belgium Ireland Norway Latvia Austria United Kingdom* Luxembourg Estonia Portugal % 2% 4% 6% 8% 1% migrant HIV cases native cases origin unkown * Unknown origin: UK collected in country of probable infection of which missing information was observed in 24% of cases ** Spain data: 25 Figure 4 Proportion of migrants among HIV infections reported in 26 in 23 EU countries plus Norway and Iceland. Countries are classified in five groups according to HIV incidence rates per million populations. Asterisk indicates unknown origin: based in country of probable infection, missing information was observed in 24% of cases and double asterisk indicate Spain data: 25 Discussion Migrant populations, largely Sub-Saharan Africans, represented a considerable and growing proportion of both AIDS cases and HIV infections reported in the 27 EU countries, Norway and Iceland during 1999 26. The drop in AIDS cases observed in native populations is seen only in migrants from Western countries, while in migrants from other geographical origins increases are seen. The contribution of migrants to the AIDS and HIV epidemics is notably higher among female reports, in particular for women from SSA. Closely linked to the high burden of HIV infection in women from SSA is the high proportion of migrants from SSA among MTCH HIV reports. Although the largest proportion of migrants is, by far, among heterosexually acquired HIV and AIDS reports, a significant percentage of Downloaded from https://academic.oup.com/eurpub/article-abstract/21/5/62/5141 on 3 January 218 diagnoses in MSM are also migrants, largely from Western Europe and Latin-America and North-Africa and Middle East. A higher proportion of migrants developed TB as their initial ADC compared with natives; people from SSA and Eastern Europe had the highest prevalence of TB, closely followed by people from Southeast Asia. There is substantial heterogeneity in the proportion of migrants among AIDS cases and HIV infections between EU countries being notably higher in Northern and Western EU countries compared with Eastern and Central EU. The number of AIDS reports from most EU countries experienced a marked decline from the mid-199s onwards, largely attributed to the impact of High Activity Antiretroviral Therapy (HAART). 6,7 However, for migrants from outside Western European countries actual increases are observed that may respond to late diagnosis of HIV

Epidemiology of HIV infection in Europe 625 infection, poor access and response to HAART or immigration of people with advanced HIV disease. Our results are in line with an article by Prost et al., where authors identify that the features affecting Sub-Saharan African migrants living with HIV/AIDS in Europe are more advanced disease at diagnosis, higher TB rates, major difficulties related to immigration status, social discrimination and stigma and high levels of poverty and unemployment. 8 Delayed diagnosis of HIV infection is a major public health problem in the EU, and various publications suggest that this trend is commoner in migrants. 7 13 Poorer response to HAART has also been described. 14 The contribution of migrants to national HIV epidemics is heterogeneous in the EU as it depends on migration patterns, neo-colonial history, state of HIV epidemics in countries of origin and destination and health and social responses. The heterogeneity in the proportion of migrants among HIV/ AIDS cases between the EU found in this study is consistent with migratory trends; countries with high proportion of migrants among HIV cases are also the countries with higher proportion of migrants in the general population. 15 The contribution of migrants, largely from SSA, to the number of HIV reports in the EU is higher in female reports. Among HIV reports in women with known geographical origin, the number of HIV-positive women from SSA outnumbers that of native women and that of HIV-positive African men, whereas the number of registered African women in population registries across the EU does not outnumber that of African men. 15 Acknowledging the limitations resulting from a high proportion of missing information and various possible explanations such as selective HIV testing of women from SSA during pregnancy, these data suggest that women from SSA, not only in their countries of origin, but also when migrating to another country, suffer a greater burden of HIV disease. 1 The reasons for female vulnerability to HIV infection have both social and biological bases 16 and the need to address gender vulnerability within migrants is needed. 17 Closely linked to the high burden of HIV infection in women from SSA is the high proportion of migrants from SSA among MTCH reports. Close to 4% of the HIV infections through MTCT were from SSA and this proportion has increased from 1999 to 26. Given that geographical origin is not always equivalent to country of birth and acknowledging that some of these children may have been born to HIV-infected mothers outside the EU, it is likely that some of these children have been infected by HIV due to failure to diagnose and treat their mothers in the EU. While the decreases in perinatal HIV infections in the EU represent an important achievement in public health, substantial challenges remain, particularly among migrant mothers. 18,19 In France, testing during pregnancy was the commonest reason to diagnose HIV in women from SSA. 19 Though HIV-positive African women presented later to antenatal care, once they accessed, uptake of HIV treatment and elective caesarean section was the same than French women. 19 We have identified a considerable proportion of migrants among HIV diagnoses in MSM, mainly from other Western EU countries, Latin-America and North-Africa and Middle East. MSM are hardly ever acknowledged when addressing the HIV epidemic in migrant populations. 2 Although numerically inferior to heterosexuals, their contribution is not negligible and it has distinct characteristics. MSM may share with the heterosexual population some reasons to migrate but also have specific reasons related to homophobia. While homophobia may certainly be a driving factor for abandoning ones country in MSM from Western countries, it is more of an issue for MSM from many countries where basic human rights for gay people are violated. These figures Downloaded from https://academic.oup.com/eurpub/article-abstract/21/5/62/5141 on 3 January 218 highlight the need to acknowledge the sexual diversity of migrants living with HIV/AIDS in Europe. These data do not allow distinguishing where actually HIV infection occurred. Other reports suggest that most heterosexually acquired HIV infections among Sub-Saharan Africans are likely to have been acquired in countries of origin. 21,22 Recently, Burns et al. have published that as many as a quarter of HIV infections diagnosed among heterosexuals and half among gay men from SSA acquired the infection in the UK. 23 Given that the majority of people tend to choose sexual partners within their own communities, assortative sexual mixing may take place. 24 Fenton et al., documented the high proportion of people engaging in unprotected sex when travelling to home countries. 25 Discussing country of probable infection is extremely controversial as it has, unfortunately, given rise to racist reactions but understanding where HIV infections and development of AIDS take place has important implications from a public health perspective as it may represent failure in primary HIV prevention, secondary HIV prevention or both. These data have to be interpreted in the context of certain limitations. Former EuroHIV recommended deriving information on geographical origin from nationality or from country of birth which may lead to misclassification. 26 The role of selective HIV testing in migrants may also lead to overestimates of HIV prevalence when compared with groups not exposed to similar testing practices. This is particularly relevant for women from SSA who may be more exposed to antenatal HIV screening than men and native women who have lower numbers of children. The overall increase in HIV infections has to be interpreted in the context of the implementation of HIV reporting which is not yet complete and may have led to an overestimate of this trend. The absence of HIV reporting systems in some countries and poor completion of the variable geographical origin in others is a caveat in interpreting figures. Finally, most countries do not collect information on ethnic background in healthinformation systems and in many it is not allowed. 26 It is likely that HIV is affecting disproportionately ethnic minorities in the EU who are currently invisible to surveillance systems that will be classified as natives as their country of origin is the same as the country of report. The most recent ECDC figures from the surveillance strategy 28 12 also reflect the high proportion of migrants among HIV-positive people in all transmission categories. Although some variable coding changes may hamper complete comparability with the data presented here, these most recent figures highlight that the number of new HIV diagnoses acquired heterosexually in migrants from countries with generalized epidemics seems to have halted. However, given the high number of missing values for the geographical origin variable, care has to be taken in interpreting these trends. 27 Our data confirms that failure of both primary and secondary HIV prevention in migrant populations is taking place, especially migrant women, and urgent action is needed. Controlling the HIV/AIDS epidemic implies breaking barriers to HIV prevention and treatment. 28 These barriers have a hierarchical structure and it has to be stated that in a framework of prosecution of migrants, irrespective of their administrative and legal residency status, public-health strategies and recommendations aimed to decrease language, cultural and gender barriers are bound to fail. Fear of deportation will abort many of the public-health initiatives aimed to prevent HIV and AIDS in migrants. Since the early days of the HIV epidemic, it became clear that ensuring the rights of the PLWHA were the pillars of the fight against the epidemic. This is still the framework that is needed to fight HIV/AIDS in migrant communities in the EU.

626 European Journal of Public Health Acknowledgements The authors are grateful for funds provided by CIBERESP (Spain) and RIS (RD6/6). Funding This work was commissioned by the ECDC as a restricted call for tende. Conflicts of interest: None declared. Key points These are the first data to quantify that migrants, largely from SSA, represent a considerable proportion of AIDS and HIV reports in EU, especially among heterosexual and MTCT infections, and that their contribution is higher among female reports. Although the largest proportion of migrants is, by far, among heterosexually acquired HIV and AIDS reports, a significant percentage of diagnoses in MSM are also migrants, largely from Western Europe and Latin-America and North-Africa and Middle East. A higher proportion of migrants developed TB as their initial ADC compared with natives. The declines seen in the number of AIDS cases in EU from the mid-199s onwards are not seen in migrants from outside Western European countries, where actual increases are observed. These data confirm that failure of both primary and secondary HIV prevention in migrant populations in Europe is taking place, especially migrant women, and urgent action is needed. References 1 UNAIDS. 28 Report on the Global AIDS Epidemic. Available at: http:// www.unaids.org/ (November 28, date last accessed). 2 International Organization for Migration. Available at: http://www.iom.int (November 28, date last accessed). 3 Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, Trends in Total Migrant Stock: The 25 Revision Availabe at: http://esa.un.org/migration (3 May 29, date last accessed). 4 UNAIDS. International Guidelines on HIV/AIDS and Human Rights. 26 Consolidated Version. Available at: http://www.unaids.org/ (November 28, date last accessed). 5 Hamers FF, Downs AM. The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet 24;364:83 94. 6 European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe: End-year report 26. N 75. Available at: http:// www.eurohiv.org/ (November 28, date last accessed). 7 CASCADE Collaboration.Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 23;362:1267 74. 8 Prost A, Elford J, Imrie J, et al. Social, behavioural, and intervention research among people of Sub-Saharan African origin living with HIV in the UK and Europe: literature review and recommendations for intervention. AIDS Behav 28;12:17 94. 9 Coenen T, Lundgren J, Lazarus JV, Matic S. Optimal HIV testing and earlier care: the way forward in Europe. HIV Med 28;9(Suppl 2):1 5. 1 Sobrino P, García L, Caro AM, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res 29;7:224 3. 11 Lanoy E, Mary-Krause M, Tattevin P. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 27;12:89 96. 12 Wolbers M, Bucher HC, Furrer H. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 28;9:397 45. 13 Caro AM, Gutiérrez F, Ramos JM, et al. Infection in migrants in Spain: epidemiological characteristics and clinical presentation in the CoRIS Cohort, 24-26. Enferm Infecc Microbiol Clin 29;27:38 8. 14 Dray-Spira R, Spire B, Heard I, Lert F and VESPA Study Group. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study. AIDS 27;21(Suppl 1):S5 12. 15 Eurostat. Available at: http://ec.europa.eu/eurostat/ (November 28, date last accessed). 16 Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 25;38:1582 3. 17 Llácer A, Zunzunegui MV, Del Amo J, et al. The contribution of a gender perspective to the understanding of migrants health. J Epidemiol Comm Health 27;61(Suppl 2):ii4 1. 18 Jasseron C, Mandelbrot L, Tubiana R, et al. ANRS French Perinatal Cohort. Prevention of mother-to-child HIV transmission: similar access for sub-sahara African immigrants and for French women? AIDS 28;22:153 11. 19 Perinatal transmission of HIV in England: 22-25. Available at: www.nshpc.ucl.ac.uk (November 28, date last accessed). 2 Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2-26. AIDS 28;22:973 81. 21 Dougan S, Elford J, Rice B, et al. Epidemiology of HIV among black and minority ethnic men who have sex with men in England and Wales. Sex Transm Infect 25;81:345 5. 22 Sinka K, Mortimer J, Evans B, Morgan P. Impact of the HIV epidemic in sub-saharan Africa on the pattern of HIV in the UK. AIDS 23;17:1683 9. 23 Burns FM, Arthur G, Johnson AM, et al. SONHIA collaboration group. United Kingdom acquisition of HIV infection in African residents in London: more than previously thought. AIDS 29;23:262 6. 24 Kramer MA, van Veen MG, de Coul EL, et al. Migrants travelling to their country of origin: a bridge population for HIV transmission? Sex Transm Infect 28;84:554 5. 25 Fenton KA, Chinouya M, Davidson O, et al. the MAYISHA research team. HIV transmission risk among sub-saharan Africans in London travelling to their countries of origin. AIDS 21;15:1442 5. 26 Del Amo J, Broring G, Hamers F, et al. Monitoring HIV/AIDS in migrants communities in Europe. AIDS 24;18:1867 73. 27 European Center for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 28. Stockholm: ECDC, 29. 28 Fakoya I, Reynolds R, Caswell G, Shiripinda I. Barriers to HIV testing for migrant black Africans in Western Europe. HIV Med 28;9 (Suppl 2):23 5. Downloaded from https://academic.oup.com/eurpub/article-abstract/21/5/62/5141 on 3 January 218